A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

Transplantation
M MartinD Kisor

Abstract

Cytomegalovirus disease is an important cause of morbidity following liver transplantation. To date there has not been an effective prophylaxis for CMV disease after liver transplantation. One hundred forty-three patients were randomized to receive either high dose oral acyclovir (800 mg 4 times a day) alone for 3 months after transplantation (acyclovir group) or intravenous ganciclovir (5 mg/kg twice a day) for 14 days followed by high dose oral acyclovir to complete a 3-month regimen (ganciclovir group). Of 139 patients available for evaluation, 43 of 71 (61%) patients from the acyclovir group developed CMV infection compared with 16 of 68 (24%) from the ganciclovir group (relative risk, 3.69; 95% confidence interval, 2.07-6.56; P < 0.00001). Of those randomized, CMV disease was seen in 20 (28%) of the acyclovir group compared with 6 (9%) of the ganciclovir group (relative risk, 5.11; 95% confidence interval, 2.05-12.75; P = 0.0001). The median time to onset of CMV infection was 45 days in the acyclovir group compared with 78 days in the ganciclovir group (P = 0.004). The median time to onset of CMV disease was 40 days in the acyclovir group compared with 78 days in the ganciclovir patients (P = 0.02). With respect to primary...Continue Reading

Citations

Mar 17, 2000·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·P Sampathkumar, C V Paya
Mar 12, 1999·The Surgical Clinics of North America·G V MazariegosD J Kramer
Mar 27, 2001·Transplantation Proceedings·S So
Aug 1, 1996·Journal of Hepatology·D Mutimer
Oct 4, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Rafael E de la HozChristopher Sherlock
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·L BarkholtJ Andersson
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·S KusneJ Fung
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·J S Villacian, C V Paya
Feb 28, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Yvon CalmusDaniele Girault
Feb 22, 2003·Surgical Infections·D E Fry
Jun 6, 2000·The Journal of Antimicrobial Chemotherapy
May 15, 1996·Transplantation·R PatelC V Paya
Nov 26, 2004·Drugs·Michelle SlifkinDavid R Snydman
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·R Abu-Nader, R Patel
Aug 30, 2008·World Journal of Gastroenterology : WJG·Raymund Rabe Razonable
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A Das
May 11, 2012·Enfermedades infecciosas y microbiología clínica·Elisa Cordero Matía, Oscar Len
Dec 19, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A EgliH H Hirsch
Sep 19, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Maria Cristina KeightleyKirsten St George
Apr 9, 2001·Clinics in Liver Disease·H S Te, A L Baker
Dec 19, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K MumtazP S Shah
Feb 22, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Lisbeth BarkholtAnneka Ehrnst
Jan 1, 1997·Transplant International : Official Journal of the European Society for Organ Transplantation·J GavaldàA Pahissa
Dec 31, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Shimon Kusne, Janis E Blair
Jul 20, 2007·The Cochrane Database of Systematic Reviews·C Couchoud-Heyer
Jul 13, 2005·Transplant International : Official Journal of the European Society for Organ Transplantation·Daniel SeehoferPeter Neuhaus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.